Kullanım Kılavuzu
Neden sadece 3 sonuç görüntüleyebiliyorum?
Sadece üye olan kurumların ağından bağlandığınız da tüm sonuçları görüntüleyebilirsiniz. Üye olmayan kurumlar için kurum yetkililerinin başvurması durumunda 1 aylık ücretsiz deneme sürümü açmaktayız.
Benim olmayan çok sonuç geliyor?
Birçok kaynakça da atıflar "Soyad, İ" olarak gösterildiği için özellikle Soyad ve isminin baş harfi aynı olan akademisyenlerin atıfları zaman zaman karışabilmektedir. Bu sorun tüm dünyadaki atıf dizinlerinin sıkça karşılaştığı bir sorundur.
Sadece ilgili makaleme yapılan atıfları nasıl görebilirim?
Makalenizin ismini arattıktan sonra detaylar kısmına bastığınız anda seçtiğiniz makaleye yapılan atıfları görebilirsiniz.
 Görüntüleme 27
 İndirme 7
The Metastatic Lymph Node Ratio Is A Crucial Criterion In Colorectal Cancer Therapy Management and Prognosis
2022
Dergi:  
European Archives of Medical Research
Yazar:  
Özet:

Objective: Every year, 1.8 million people are diagnosed with colon cancer. The presence of lymph node (LN) metastases is a key prognostic factor in adjuvant treatment planning and follow-up. The tumor-node-metastasis (TNM) classification can be used to assist in prognostic cancer staging. However, TNM-classification may not always compromise the necessary prognostic information. Therefore, guidelines are updated regarding prognostic value and new prognostic parameters are investigated. One of these parameters is metastatic lymph node ratio (mLNR), which is calculated by dividing the number of metastatic lymph nodes (mLNs) by the total number of lymph nodes excised. Similar publications have already reported on the prognostic value of the mLNR in gastric, pancreatic, and bladder cancer. Methods: Pathology reports of 496 stage II and stage III patients treated for colorectal cancer (CRC) in our hospital in the last decade were retrospectively reviewed. Factors such as age, gender, tumor location, tumor size, T stage, lymphovascular invasion, perineural invasion, tumor budding, tumor deposit, total and mLN count were evaluated for overall survival. Results: The mean tumor size was 53.8 mm. The patients who had an average of 2 LN involvement among those who had 23 lymph nodes excised were followed up for an average of 66.8 months. Receiver operating characteristic test presented the cut-off value of mLNR on overall survival was 0.028, with a sensitivity of 42% and a specificity of 71%. Gender, tumor’s localization, and size of ≥6 cm had no significant impact on survival. However, survival was related to age >60, lymphovascular, and perineural invasion, tumor deposit/budding, and mLNR >0.028 (p≤0.05). Furthermore, multivariate analysis revealed that only mLNR (p=0.034) affected overall survival independently. Conclusion: We believe that mLNR that does not require additional costs will gain more value in diagnosis and treatment. Based on our results, mLNR may be a useful to assess prognosis in CRC patients.

Anahtar Kelimeler:

2022
Yazar:  
0
2022
Yazar:  
Atıf Yapanlar
Bilgi: Bu yayına herhangi bir atıf yapılmamıştır.
Benzer Makaleler










European Archives of Medical Research

Alan :   Sağlık Bilimleri

Dergi Türü :   Uluslararası

Metrikler
Makale : 145
Atıf : 9
© 2015-2024 Sobiad Atıf Dizini